Joseph P. Barsuglia - Concepedia

Author

Joseph P. Barsuglia

University of California, Los Angeles ORCID

Also Known As

Joseph Barsuglia, Joseph P Barsuglia, Joseph P. Barsuglia, Joseph Peter Barsuglia

Publications

790

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Yale University Johns Hopkins University VA Greater Los Angeles Healthcare System Behavioral Pharma (United States)

About

Joseph P. Barsuglia is an author at University of California, Los Angeles specializing in medicine, pharmacotherapy, and substance abuse.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	161
2	Health Sciences	4	4	147
3	Social Sciences	1	1	14
4	Neurology	1	1	14
5	Neuroscience	1	1	14

Joseph P. Barsuglia

Publications

788

Citations

H-Index

Page 1

	Year	Citations
5-methoxy-<i>N,N</i>-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety Alan K. Davis, Sara So, Rafael Lancelotta, The American Journal of Drug and Alcohol Abuse	2019	132
The epidemiology of 5-methoxy-<i>N, N</i>-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption Alan K. Davis, Joseph P. Barsuglia, Rafael Lancelotta, Journal of Psychopharmacology	2018	130
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study Joseph P. Barsuglia, Alan K. Davis, Robert L. Palmer, Frontiers in Psychology	2018	79
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda, Chronic Stress	2020	74
Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine Benjamin Malcolm, Martín Polanco, Joseph P. Barsuglia Journal of Psychoactive Drugs Opioid EpidemicSubstance UsePharmacotherapyIbogaine AdministrationUnited States	2018	61
Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning Alan K. Davis, Joseph P. Barsuglia, Austin-Marley Windham-Herman, Journal of Psychedelic Studies	2017	55
A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder Joseph P. Barsuglia, Martín Polanco, Robert L. Palmer, Progress in brain research Substance UsePsychopharmacologyPharmacotherapyTheoretical RationaleSubstance Use Disorders	2018	34
A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification Alan K. Davis, Elise Renn, Austin-Marley Windham-Herman, Journal of Psychoactive Drugs Gastrointestinal PharmacologyPharmacotherapyMental HealthPsychologyTreatment Responders	2018	33
Neuropsychological and Neuroanatomical Correlates of the Social Norms Questionnaire in Frontotemporal Dementia Versus Alzheimer’s Disease Hemali Panchal, Pongsatorn Paholpak, Grace Lee, American Journal of Alzheimer s Disease & Other Dementias®	2015	32
Evaluation of Emotional Blunting in Behavioral Variant Frontotemporal Dementia Compared to Alzheimer's Disease Simantini J. Karve, Joseph P. Barsuglia, Michelle Mather, Dementia and Geriatric Cognitive Disorders	2014	28

Page 1